Drug-target residence time and its implications for lead optimization
- PMID: 16888652
- DOI: 10.1038/nrd2082
Drug-target residence time and its implications for lead optimization
Erratum in
- Nat Rev Drug Discov. 2007 Mar;6(3):249
Abstract
Much of drug discovery today is predicated on the concept of selective targeting of particular bioactive macromolecules by low-molecular-mass drugs. The binding of drugs to their macromolecular targets is therefore seen as paramount for pharmacological activity. In vitro assessment of drug-target interactions is classically quantified in terms of binding parameters such as IC(50) or K(d). This article presents an alternative perspective on drug optimization in terms of drug-target binary complex residence time, as quantified by the dissociative half-life of the drug-target binary complex. We describe the potential advantages of long residence time in terms of duration of pharmacological effect and target selectivity.
Similar articles
-
The importance of drug-target residence time.Curr Opin Drug Discov Devel. 2009 Jul;12(4):488-96. Curr Opin Drug Discov Devel. 2009. PMID: 19562645 Review.
-
Conformational adaptation in drug-target interactions and residence time.Future Med Chem. 2011 Sep;3(12):1491-501. doi: 10.4155/fmc.11.112. Future Med Chem. 2011. PMID: 21882942
-
A rational approach to maximize success rate in target discovery.Arch Pharm (Weinheim). 2004 Dec;337(12):625-33. doi: 10.1002/ardp.200400913. Arch Pharm (Weinheim). 2004. PMID: 15597396
-
[Development of antituberculous drugs: current status and future prospects].Kekkaku. 2006 Dec;81(12):753-74. Kekkaku. 2006. PMID: 17240921 Review. Japanese.
-
Designing transient binding drugs: a new concept for drug discovery.Drug Discov Today. 2008 May;13(9-10):433-9. doi: 10.1016/j.drudis.2008.02.001. Epub 2008 Mar 18. Drug Discov Today. 2008. PMID: 18468561 Review.
Cited by
-
A Probe-Free Occupancy Assay to Assess a Targeted Covalent Inhibitor of Receptor Tyrosine-Protein Kinase erbB-2.ACS Pharmacol Transl Sci. 2024 Aug 1;7(8):2507-2515. doi: 10.1021/acsptsci.4c00326. eCollection 2024 Aug 9. ACS Pharmacol Transl Sci. 2024. PMID: 39144565
-
Pseudoirreversible inhibition elicits persistent efficacy of a sphingosine 1-phosphate receptor 1 antagonist.Nat Commun. 2024 Jul 19;15(1):5743. doi: 10.1038/s41467-024-49893-8. Nat Commun. 2024. PMID: 39030171 Free PMC article.
-
Highly Selective Drug-Derived Fluorescent Probes for the Cannabinoid Receptor Type 1 (CB1R).J Med Chem. 2024 Jul 25;67(14):11841-11867. doi: 10.1021/acs.jmedchem.4c00465. Epub 2024 Jul 11. J Med Chem. 2024. PMID: 38990855 Free PMC article.
-
Know your molecule: pharmacological characterization of drug candidates to enhance efficacy and reduce late-stage attrition.Nat Rev Drug Discov. 2024 Aug;23(8):626-644. doi: 10.1038/s41573-024-00958-9. Epub 2024 Jun 18. Nat Rev Drug Discov. 2024. PMID: 38890494 Review.
-
Flipping the GPCR Switch: Structure-Based Development of Selective Cannabinoid Receptor 2 Inverse Agonists.ACS Cent Sci. 2024 Mar 11;10(5):956-968. doi: 10.1021/acscentsci.3c01461. eCollection 2024 May 22. ACS Cent Sci. 2024. PMID: 38799662 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources